Eli Lilly ITSW
A Study of LY900014 in participants with Type 2 Diabetes using Continuous Glucose Monitoring

Type of Study:
Single treatment group to evaluate the amount of time the sensor glucose values from CGM are within target range with 12 weeks of LY900014

Study Length:
12 Weeks

Target Age/Sex:
over 18 years, Male and Female

Benefits:
Participants will receive at no cost: study product, study materials and study-specific procedures

Staus: Enrolling

Description:

This is a study of LY900014 in participants with Type 2 Diabetes using Continuous Glucose Monitoring.

Enroll Now

Enroll Now

Address
Address
City
State/Province
Zip/Postal
If you don't have a primary care physician, just type "Do not have a primary care physician"